Centrality of G6PD in COVID-19: The Biochemical Rationale and Clinical Implications Front Med (Lausanne). 2020 Oct 22;7:584112. doi: 10.3389/fmed.2020.584112. eCollection 2020. November 2020 ABSTRACT Introduction: COVID-19 is a novel and devastating disease....
Methemoglobinemia in Patient with G6PD Deficiency and SARS-CoV-2 Infection
Methemoglobinemia in Patient with G6PD Deficiency and SARS-CoV-2 Infection — Volume 26, Number 9—September 2020; Research Letter by Kieran Palmer, Jonathan Dick, Winifred French, Lajos Floro, and Martin Ford Author affiliations: King’s College Hospital National Health...
Treatment with Hydroxychloroquine Cut Death Rate Significantly in COVID-19 Patients, Henry Ford Health System Study Shows
Treatment with Hydroxychloroquine Cut Death Rate Significantly in COVID-19 Patients, Henry Ford Health System Study Shows — July 2020; Henry Ford Health System DETROIT – Treatment with hydroxychloroquine cut the death rate significantly in sick patients...
Glucose-6-Phosphate Dehydrogenase Deficiency: An Actionable Risk Factor for Patients with COVID-19?
Glucose-6-Phosphate Dehydrogenase Deficiency: An Actionable Risk Factor for Patients with COVID-19? June 7, 2020 – Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common X-linked mutation that is more prevalent in African, Asian, Latin American and...
Does G6PD Deficiency Relate to COVID-19 Infection?
Does G6PD Deficiency Relate to COVID-19 Infection? — Several hints of one, pointing to need for focused research by Dan J. Vick MD, DHA, MBA, CPE April 2020 - In an April 8 MedPage Today article, Mark Zucker, MD, asked the question as to why there is...